Agile Therapeutics

AGRX78

Penny Stock

$1.510.00%$0.00

Penny Stock

AGRX78

$1.51

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$1.51
Prev. Close	$1.51
EPS	-1.70
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$10.42M
PE Ratio	-

	LOW	HIGH
Day Range	1.51	1.51
52 Week Range	0.20	2.63

Ratios

Revenue	-





EPS	-1.70

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Agile Therapeutics (AGRX)

Agile Therapeutics Inc (AGRX) is a biopharmaceutical company focused on the development and commercialization of women's healthcare products. The company's flagship product is Twirla, a non-daily, low-dose contraceptive patch. Twirla is designed to provide effective contraception for women of reproductive age. It utilizes a proprietary transdermal patch technology that allows for the delivery of hormones through the skin. Agile Therapeutics aims to offer women a convenient, reliable, and discreet contraceptive option.

The stock price history of Agile Therapeutics Inc shows a volatile trend over the years. There have been significant fluctuations in the stock price, influenced by various factors such as clinical trial results, regulatory news, and market conditions. Investors should carefully monitor these factors and conduct a thorough analysis before making any investment decisions. It is important to note that past performance is not indicative of future results.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Alfred F. Altomari
Headquarters: Princeton
Employees: 22
Exchange: NASDAQ

Keep an eye on Agile Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Agile Therapeutics 's (AGRX) price per share?

The current price per share for Agile Therapeutics (AGRX) is $1.51. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Agile Therapeutics (AGRX)?

For Agile Therapeutics (AGRX), the 52-week high is $2.63, which is 74.17% from the current price. The 52-week low is $0.2, the current price is 655% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Agile Therapeutics (AGRX) a growth stock?

Agile Therapeutics (AGRX) has shown an average price growth of 0.41% over the past three years. It has received a score of -7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Agile Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Agile Therapeutics (AGRX) stock price performance year to date (YTD)?

As of the latest data, Agile Therapeutics (AGRX) has a year-to-date price change of -17.93%. Over the past month, the stock has experienced a price change of 3.42%. Over the last three months, the change has been 344.12%. Over the past six months, the figure is 178.08%. Looking at a longer horizon, the five-year price change stands at -99.95%.

help

Is Agile Therapeutics (AGRX) a profitable company?

Agile Therapeutics (AGRX) has a net income of -$14.46M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 54.18% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -49.25% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 80.02%, providing insight into the company's sales performance and growth. The gross profit is $10.62M. Operating income is noted at -$19.88M. Furthermore, the EBITDA is -$13.15M.

help

What is the market capitalization of Agile Therapeutics (AGRX)?

Agile Therapeutics (AGRX) has a market capitalization of $10.43M. The average daily trading volume is 88.98K, indicating the stock's liquidity and investor engagement.